Altamira Therapeutics to Develop Novel Generation of Rheumatoid Arthritis Therapeutics Based on its Proprietary OligoPhore Delivery Platform and siRNA Targeting Key Inflammation Checkpoint
•Company’s novel drug development program AM-411 builds on positive animal data •Treatments for rheumatoid arthritis…
How to Future-Proof Your Company with Smarter IT Choices
BOSS Zhipin Continues Share Repurchases: More than RMB340M in 2026 Under Buyback Program